Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 12 Sep 2025

Application of immunotherapy in advanced non-small cell lung cancer with hypertension: a multicenter retrospective analysis

in Cancer Immunity and Immunotherapy

Jingyi Yuan
Kaixin Lei
Quanling Kong
Tao Chang
Xinhang Gu
Juan Wang
Li-na He
Jiadi Gan
Bojiang Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1621363

1,498 views

Correction

Published on 11 Sep 2025

Correction: PNI as a predictive biomarker: a novel nomogram of immunotherapy efficacy in advanced breast cancer

in Cancer Immunity and Immunotherapy

Xinyang Li
Xiang Cheng
Yikai Han
Xiaodan Liu
Yujin Fang
Shengju Ren
Xiangwen Dong
Ziwen Lei
Yue Zhang
Tengfei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1694570

339 views

Case Report

Published on 11 Sep 2025

Long-term complete remission with immunotherapy in advanced RET fusion-positive NSCLC with brain metastases: a case report and literature review

in Cancer Immunity and Immunotherapy

Shuheng Shang
Meng Qin
Shuangmei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1597110

439 views

Systematic Review

Published on 11 Sep 2025

The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials

in Cancer Immunity and Immunotherapy

Yun Xu
Baoliang Zhong
Chunlin Yu
Qingjian Hou
Wenying Chen
Wen Zheng
Wenxiong Zhang
Tonggang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1590017

355 views

Case Report

Published on 11 Sep 2025

Atezolizumab-induced vanishing bile duct syndrome: a case report

in Cancer Immunity and Immunotherapy

Carlos Tomás Noblejas Quiles
José Antonio Macías Cerrolaza
Javier David Benitez Fuentes
Laura López Gómez
Manuel Sánchez Cánovas
María Nevado Rodríguez
Miguel Martín Cascón
Isabel Vigueras Campuzano
Asunción Chaves Benito
Antonio David Lázaro Sánchez

Frontiers in Oncology

doi 10.3389/fonc.2025.1637847

367 views

Case Report

Published on 10 Sep 2025

Successful rescue of PD-1 inhibitor-induced TEN by vincristine combination therapy: a case report and literature review

in Cancer Immunity and Immunotherapy

Hui-Yi Huang
Jia-Qi Liu
Yun-Yun Zeng
Zhi-Hao Huang
Shan Su

Frontiers in Oncology

doi 10.3389/fonc.2025.1621494

269 views

Original Research

Published on 10 Sep 2025

Comprehensive prognostic model for immunotherapy in small cell lung cancer: a multi-center study integrating clinical and blood biomarkers

in Cancer Immunity and Immunotherapy

Qiuqiao Mu
Yuhao Jing
Yun Ding
Jingxian Wang
Han Zhang
Yuhang Jiang
Lin Tan
Jie Zhang
Xin Li
Daqiang Sun

Frontiers in Oncology

doi 10.3389/fonc.2025.1680624

296 views

Original Research

Published on 10 Sep 2025

Analyzing the impact of human leukocyte antigen mismatch on the incidence of prostate cancer and the advantage of T cell therapy in patients after kidney transplantation based on the United Network for Organ Sharing database

in Cancer Immunity and Immunotherapy

Yang Gao
Jingjing Li
Jiaxi Mao
Aijun Jiang
Wenyuan Guo
Shangxi Fu

Frontiers in Oncology

doi 10.3389/fonc.2025.1562869

380 views

Review

Published on 10 Sep 2025

Integrating single-cell omics and materials science for uveal melanoma: from mechanistic insights to precision therapeutics

in Cancer Immunity and Immunotherapy

Shouyong Fu
Changfei Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1661889

628 views

Original Research

Published on 10 Sep 2025

CCDC58 drives lung adenocarcinoma progression via the PI3K/AKT signaling pathway

in Cancer Immunity and Immunotherapy

Wenchao Dai
Jun Yang
Wenming Yang
Guibin Zhang
Hang Chen
Bi Ren
Xin Dang
Linfeng Xue
Li Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1619123

445 views

Original Research

Published on 10 Sep 2025

Phenotypes of synovial fluid Treg cells in checkpoint blockade-related inflammatory arthritis

in Cancer Immunity and Immunotherapy

Heyu He
Ning Zhou
Kaidi Wu
Junhong Lin
Shaowei Zhou
Yuntao Gu
Xinjia Wang
Weidong Wang
Lichuan Mo
Chuanzhu Lv

Frontiers in Oncology

doi 10.3389/fonc.2025.1628790

272 views

Case Report

Accepted on 09 Sep 2025

Immune-related Osteitis mimicking Femoral Head Osteonecrosis during Dual Checkpoint Blockade: A case report

in Cancer Immunity and Immunotherapy

Enrica Teresa Tanda
Agostina Lagodin D'Amato
Giovanni Rossi
Maria Maddalena Latocca
Andrea Boutros
Andrea Zanirato
Matteo Formica
Silvia Bozzano
Bruno Spina
Francesco Spagnolo

Frontiers in Oncology

doi 10.3389/fonc.2025.1621774

102 views

Original Research

Accepted on 08 Sep 2025

Pressure enabled drug delivery (PEDD) of nelitolimod increased therapeutic delivery, reduced immunosuppression, and improved efficacy in porcine and murine liver tumor models

in Cancer Immunity and Immunotherapy

Lauren Cournoyer
Yujia Liu
David B Jaroch
Tom G Hullinger
Bryan F Cox
Steven C Katz
Jason LaPorte
Ilan B Layman
Alizee Ballarin
CHANDRA C GHOSH

Frontiers in Oncology

doi 10.3389/fonc.2025.1655794

254 views

Original Research

Accepted on 08 Sep 2025

Efficacy and safety of immune checkpoint inhibitor rechallenge therapy in the treatment of advanced acquired immune-resistant nonsmall cell lung cancer: a retrospective study

in Cancer Immunity and Immunotherapy

Jian Wang
Qijia Gao
Jianxin Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1621860

226 views

Case Report

Accepted on 08 Sep 2025

Bowen's disease treated with PD-1 inhibitor and chemotherapy

in Cancer Immunity and Immunotherapy

xiaohui xie
qinyang chen
jian zhang
Xiaodong Peng

Frontiers in Oncology

doi 10.3389/fonc.2025.1654431

168 views

Original Research

Published on 08 Sep 2025

Blood memory CD8 T cell phenotypes in lung cancer patients predict immune checkpoint treatment responses

in Cancer Immunity and Immunotherapy

Florian Schmidt
Kan Xing Wu
Yovita Ida Purwanti
Nicholas Yan Zhi Tan
Daniel Carbajo
Ke Xin Bok
Andreas Wilm
Michael Fehlings
Daniel MacLeod
Alessandra Nardin

Frontiers in Oncology

doi 10.3389/fonc.2025.1629802

487 views